Conclusion For more than a century, Novo Nordisk has been at the forefront of endocrine and metabolic innovation , shaping how chronic diseases are managed worldwide
These treatments work exceptionally well on the face, neck, dcolletage, and hands , promoting firmer and healthier skin
This GLP-1 analogue also proved to be more effective than placebo or positive control drugs in reducing body weight, HbA1c level, fasting plasma glucose level, and BMI with overall dose-dependent efficacy
Semaglutide is the leader in the region, and combination therapies are becoming more popular
Engaging with GLP-1 users on platforms like TikTok and Instagram likely helps increase treatment awareness among younger adults, while also providing a positive example of what their own journey could look like